The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Trump says US will lift sanctions on Turkey, heaps praise on Erdogan
Suspect in Monaco bombing found dead in Ukraine
Blasts rock Damascus during Macron visit
Britain's Farage quits parliament in protest, but will stand for re-election
French court shortens Le Pen's ban from office but orders electronic tag
Israeli strikes kill two people in Gaza, medics say
At least 5 dead in major landslide in India's Wayanad
Trump says there will either be a deal with Iran or US will 'finish the job'
